ARCHIVES

NCI’s Rosenberg Confirms 2002 Immunotherapy Results

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Frederick RFP Available Oct. 22; Three Four May Challenge L-B

August 27, 1976

FDA Revises Package Insert, Seeks To Limit Product Liability Suits In State Courts.

January 20, 2006

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

November 4, 2005